알림
뒤로

Recombinant Abs[Bio X Cell] RecombiMAb™ - 연구 목적에 맞게 설계된 Recombinant 항체

Bio X Cell
조회수 247

462ea43da88c4.jpg


RecombiMAb™ - In Vivo용 Recombinant Antibodies


In vivo 연구에서는 항체의 구조와 품질이 실험 결과의 재현성과 신뢰성에 큰 영향을 줍니다.

Bio X Cell의 RecombiMAb™  항체는 recombinant 방식으로 제작되며, 

연구 목적에 맞게 최적화된 Fc 구조를 통해 안정적인 in vivo 연구를 지원합니다.


ddf4f6d62663c.png기본 분석을 위한 Fc 엔지니어링
Fc-silent 및 Fc active variant 기반으로 연구 목적에 따라 effector function 조절 가능합니다.
5b3f189b8f8fc.png동물 종 (species)에 맞춰 분자 구조 최적화
같은 항체 기반으로 면역 기능이 조절된 Fc 영역 format 선택이 가능합니다.
d76fdaecc64ba.pngIn vivo 연구를 위한 품질관리
고순도, 낮은 endotoxin, 동물성 병원체 검사, 항체 응집 검증 등 in vivo 실험을 위한 QC 와료한 항체.
ba3352c18b96b.png연구 결과에 대한 일관성
Single-lot 기반 대량 항체 생산으로 전임상 연구 연속성 유지를 지원합니다.


4c2336331676d.png



모든 RecombiMAb™ 항체는 QC 진행된 제품입니다.

RecombiMAb™ (CPXXX)
순도≥95%Endotoxin 수준≤0.5EU/mg
항체 Isotype 검증
✓
항체 응집 검증
✓
동물성 병원체 검사
✓
항원-항체 결합 검증
✓


Custom 서비스

Bio X Cell은 연구 요구에 따라 RecombiMAb™ 항체를 맞춤 제작할 수 있는 서비스를 제공합니다.

5826598e7db89.png

연구  조건에  맞춘  버퍼 및 농도 조정

2d23aba5969cc.png검출 및 multiplexing을 위한 항체 표지


79a05a7abd476.png 
Fab fragment로 변환하여 Fc 영향 없이 실험 지원
d8372f1a92d43.png
종 변경, Fc 조절 등 통해 연구 목적에 맞게 항체를 최적화


331760e1d5ae1.png
mg부터 g까지 맞춤 생산

원하는 RecombiMAb™ 제품을 확인해보세요

Myeloid & Macrophage Biology Antibodies
TargetCat. No.CloneReactivityIsotypeSize
CSF1RCP131AFS98MouseMouse IgG2a, κ1/5/25/50/100 mg
CD47CP092B6-H12MouseMouse IgG2a, κ1/5/25/50/100 mg
CD172aCP072P84MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
TREM-2CP067178MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CD11bCP071M1/70Mouse, Human Mouse IgG2a (LALA-PG), κ1/5/25 mg
CP051M1/70Mouse, HumanMouse IgG2a, κ1/5/25 mg
CD16/CD32CP0252.4G2MouseMouse IgG2a, κ1/5/25 mg
CP0262.4G2MouseMouse IgG2a, κ1/5/25 mg


Immune Cell Depletion Antibodies
TargetCat. No.CloneReactivityIsotypeSize
CD4CP090GK1.5MouseMouse IgG2a, κ1/5/25/50/100 mg
CP100GK1.5
Mouse
Mouse IgG2a (LALA-PG), κ
1/5/25/50/100 mg
CD8CP0962.43MouseMouse IgG2a, κ1/5/25/50/100 mg
CP1282.43MouseMouse IgG2b, κ1/5/25/50/100 mg
CD8aCP081YTS169.4MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CP134YTS169.4MouseMouse IgG2a, κ1/5/25/50/100 mg
CD19CP1181D3MouseMouse IgG2a, κ1/5/25/50/100 mg
CD20CP062MB20-11MouseMouse IgG2a, κ1/5/25 mg
CD25CP085PC-61MouseMouse IgG2a, λ1/5/25 mg
CP084PC-61MouseMouse IgG2a (LALA-PG), λ1/5/25 mg
CP201
7D4
Mouse
Mouse IgG2a, κ
1/5/25 mg
CD45.2CP063104.2MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
Ly6GCP0911A8MouseMouse IgG2c, κ1/5/25/50/100 mg
CP1291A8MouseMouse IgG2a, κ1/5/25/50/100 mg
Ly6G/Ly6CCP135RB6-8C5MouseMouse IgG2a, κ1/5/25/50/100 mg
CP172RB6-8C5MouseMouse IgG2b, κ1/5/25/50/100 mg


Cytokine & Immune Signaling Antibodies
TargetCat. No.CloneReactivityIsotypeSize

TGFβ

CP221
1D11.16.8
Mouse, Human, Rat, Bovine, Canine, Hamster, Monkey
Mouse IgG1 (D265A), κ
1/5/25 mg
TNFαCP054XT3.11MouseMouse IgG1, κ1/5/25 mg
CP074XT3.11MouseMouse IgG2a, κ1/5/25 mg
IFNγCP058XMG1.2MouseMouse IgG1, κ1/5/25 mg
IFNAR-1CP056MAR1-5A3MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
IL-10RCP0601B1.3AMouseMouse IgG2a, κ1/5/25 mg
CP0731B1.3AMouseMouse IgG2a (LALA-PG), κ1/5/25 mg
c-KitCP0702B8Mouse, RatMouse IgG2a, κ1/5/25 mg


Tumor Microenvironment Antibodies
TargetCat. No.CloneReactivityIsotypeSize
VEGF-ACP0612G11-2A05MouseMouse IgG2a, κ1/5/25 mg
CP202B20-4.1.1
MouseMouse IgG2a, κ
1/5/25/50/100 mg
VEGFR-2CP089DC101MouseMouse IgG2a (LALA-PG), κ1/5/25/50/100 mg
CP132DC101MouseMouse IgG2a, κ1/5/25/50/100 mg
HER2 (domain I)
CP109H2Mab-304
Mouse
Mouse IgG2a, κ
1/5/25 mg
HER2 (domain III)CP108H2Mab-19Mouse, Human, CanineMouse IgG2a,, κ1/5/25 mg
CD71 (TfR1)CP0878D3MouseMouse IgG1, κ1/5/25 mg
CP0558D3MouseMouse IgG2a, κ1/5/25 mg
CP059OX-26MouseRat IgG2a, κ1/5/25 mg
CP0788D3MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CP079OX-26Mouse, RatMouse IgG2a (LALA-PG), κ1/5/25 mg
CP130R17 217.1.3MouseMouse IgG2a, κ1/5/25/50/100 mg
CD106CP050M/K-2.7MouseMouse IgG2a, κ1/5/25 mg
CXCR2CP105Cx2Mab-1MouseMouse IgG2a, κ1/5/25 mg
CXCR3CP116Cx3Mab-4MouseMouse IgG2a, κ1/5/25/50/100 mg
CXCR4CP103Cx4Mab-1MouseMouse IgG2a, κ1/5/25 mg
CXCR6CP097Cx6MAb-1MouseMouse IgG2a, κ1/5/25 mg
FAPCP05773.3Mouse Mouse IgG2a, κ1/5/25 mg
EGFR (domain-I)CP106EMab-300MouseMouse IgG2a, κ1/5/25 mg
EGFR (domain-II)CP068EMab-301MouseRat IgG2a, κ1/5/25 mg
CP114EMab-301
MouseMouse IgG2a, k
1/5/25 mg
EGFR (domain-III)CP107EMab-88Human, MouseMouse IgG2a, κ1/5/25 mg


Immune Trafficking Antibodies
TargetCat. No.CloneReactivityIsotypeSize
CCR1CP112C1Mab-6
Mouse
Mouse IgG2a, κ
1/5/25/50/100 mg
CCR2CP104C2Mab-6MouseMouse IgG2a, κ1/5/25 mg
CCR4CP102
C4Mab-1
Mouse
Mouse IgG2a, κ
1/5/25/50/100 mg
CCR5CP101C5Mab-2MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CCR6CP115C6Mab-13MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CCR7CP099C7Mab-2MouseMouse IgG2a, κ1/5/25 mg
CCR8CP080C8Mab-2MouseMouse IgG2a, κ1/5/25 mg
LPAM-1CP086DATK32MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CP069DATK32Mouse Mouse IgG2a, κ1/5/25 mg
CD38CP052NIMR5MouseMouse IgG2a, κ1/5/25 mg
CD39CP111C39Mab-1MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
ACKR4CP098A4Mab-3MouseMouse IgG2a (LALA-PG), κ1/5/25 mg


Infectious Disease Antibodies
TargetCat. No.CloneReactivityIsotypeSize
Respiratory Syncytial VirusCP152PalivizumabVirusHuman IgG4, κ1/5/25/50/100 mg
CP161PalivizumabVirusHuman IgG11/5/25/50/100 mg
CP169PalivizumabVirusHuman IgG1, κ1/5/25/50/100 mg


Checkpoint Pathway Antibodies
TargetCat. No.CloneReactivityIsotypeSize
PD-1CP094RMP1-14MouseMouse IgG2c, κ1/5/25/50/100 mg
CP002RMP1-14MouseMouse IgG1 (D265A), κ1/5/25 mg
CP00529F.1A12™MouseMouse IgG1 (D265A), κ1/5/25 mg
CP151RMP1-14MouseMouse IgG2a (D265A), κ1/5/25/50/100 mg
CP153RMP1-14MouseMouse IgG2a (LALA_PG), κ1/5/25/50/100 mg
CP15529F.1A12™MouseMouse IgG2a, κ1/5/25/50/100 mg
CP157RMP1-14MouseMouse IgG2a, κ1/5/25/50/100 mg
CP15929F.1A12™MouseMouse IgG2a, κ1/5/25/50/100 mg
CP162RMP1-14MouseMouse IgG1, κ1/5/25/50/100 mg
CP17829F.1A12™MouseMouse IgG1, κ1/5/25/50/100 mg
CP182RMP1-14MouseRat IgG2a, κ1/5/25/50/100 mg
CP18529F.1A12MouseRat IgG2a, κ1/5/25/50/100 mg
PD-L1CP00110F.9G2™MouseMouse IgG1 (D265A), κ1/5/25 mg
CP15410F.9G2™MouseMouse IgG2a (LALA-PG), κ1/5/25/50/100 mg
CP15810F.9G2™MouseMouse IgG2a, κ1/5/25/50/100 mg
CP16810F.9G2™MouseMouse IgG1, κ1/5/25/50/100 mg
CP18410F.9G2MouseRat IgG2b, κ1/5/25/50/100 mg
PD-L2
CP023
TY25
Mouse
Mouse IgG2a, κ
1/5/25 mg
CTLA-4CP0939D9MouseMouse IgG2c, κ1/5/25 mg
CP0069D9MouseMouse IgG1, κ1/5/25 mg
CP0079D9MouseMouse IgG2a, κ1/5/25 mg
CP0089D9MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CP1469H10MouseMouse IgG1, κ1/5/25/50/100 mg
CP2049H10
Mouse
Mouse IgG2a, κ
1/5/25/50/100 mg
CP2059H10
Mouse
Mouse IgG2a (LALA-PG), κ
1/5/25/50/100 mg
LAG-3CP013C9B7WMouseMouse IgG1 (D265A), κ1/5/25 mg
CP014C9B7WMouseMouse IgG2a, κ1/5/25 mg
VISTACP05313F3MouseMouse IgG2a1/5/25 mg
CP117
13F3
MouseIgG2a (LALA-PG), κ
1/5/25 mg
CD40LCP032MR-1MouseMouse IgG1 (D265A), κ1/5/25 mg
CP033MR-1MouseMouse IgG2a, κ1/5/25 mg
CP034MR-1MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
NKG2AB6CP07516A11MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
TIGITCP119
1G9
Mouse
Mouse IgG2a (LALA-PG), κ
1/5/25 mg


Immune Activation Antibodies
TargetCat. No.CloneReactivityIsotypeSize
CD3CP082145-2C11MouseMouse IgG2a, κ1/5/25 mg
CP083145-2C11MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CD40CP088FGK4.5MouseMouse IgG2a (LALA-PG), κ1/5/25/50/100 mg
CP133FGK4.5MouseMouse IgG2a1/5/25 mg
OX40CP017OX86MouseMouse IgG2a, κ1/5/25 mg
CP018OX86MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
OX40LCP066RM134LMouseMouse IgG2a (CD134L), κ1/5/25 mg
4-1BBCP038LOB12.3MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CP095LOB12.3MouseMouse IgG2a, κ1/5/25 mg
4-1BBLCP039TKS-1MouseMouse IgG1 (D265A), κ1/5/25 mg
CP040TKS-1MouseMouse IgG2a, κ1/5/25 mg
CP041TKS-1MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
GITRCP027DTA-1MouseMouse IgG1 (D265A), κ1/5/25 mg
CP028DTA-1MouseMouse IgG2a, κ1/5/25 mg
CP029DTA-1MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
CP031DTA-1MouseMouse IgG2b (LALA-PG), κ1/5/25 mg
CD28CP042D665MouseMouse IgG2a, κ1/5/25 mg
CP043D665MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
ICOSCP203
C398.4A
Mouse, Human,
Rat, Monkey
Mouse IgG2a, κ
1/5/25/50/100 mg
ICOSLCP044HK5.3MouseMouse IgG1 (D265A), κ1/5/25 mg
CP045HK5.3MouseMouse IgG2a, κ1/5/25 mg
CP046HK5.3MouseMouse IgG2a (LALA-PG), κ1/5/25 mg
HELCP047--Mouse IgG1 (D265A), κ1/5/25/50/100 mg
CP048--Mouse IgG2a (LALA-PG), κ1/5/25/50/100 mg
CP049--Mouse IgG2b (LALA-PG), κ1/5/25 mg
CP147--Human IgG4 (S228P), κ1/5/25/50/100 mg
CP148--Human IgG4 (S228P/L235E/
P329G,(SPLEPG)), κ		1/5/25/50/100 mg
CP149--Human IgG1 (LALA-PG)1/5/25/50/100 mg
CP150--Mouse IgG2a (D265A)1/5/25/50/100 mg
CP171--Human IgG1 (N297A), κ1/5/25/50/100 mg
CP173--Human IgG1 (D265A)1/5/25/50/100 mg
CP174--Human IgG1, κ1/5/25/50/100 mg
CP175--Human IgG1 (K214R/L234F/
L235E/P331S), κ		1/5/25/50/100 mg
CP179--Human IgG1 F(ab), κ1/5/25/50/100 mg
CP180--Human IgG2, κ1/5/25/50/100 mg
CP181--Human IgG4 (S228P), λ1/5/25/50/100 mg
CP183--Human IgG4 (S228P/R409K), κ1/5/25/50/100 mg
CP186--Armenian Hamster IgG11/5/25/50/100 mg
CP187--Rat IgG1, κ1/5/25/50/100 mg
CP188--Rat IgG2a, κ1/5/25/50/100 mg
CP189--Mouse IgG1, κ1/5/25/50/100 mg
CP190--Mouse IgG2a, κ1/5/25/50/100 mg
CP191--Mouse IgG2b, κ1/5/25/50/100 mg


Isotype Control Antibodies
TargetCat. No.CloneReactivityIsotypeSize
Isotype ControlCP156MOPC-21-Human IgG2a, κ1/5/25/50/100 mg
CP160MOPC-21-Mouse IgG2a, κ1/5/25/50/100 mg


* 학술 문의: (주)다윈바이오

  Tel. 031-728-3231 / E-mail. dawinbio@dawinbio.com

#BioXCell  #InVivo #항체 #Antibody #고순도 #Endotoxin #Custom #대량생산
#Recombinant #RecombiMAb #Murine #다윈바이오 #DAWINBIO


[Bio X Cell] 오가노이드 연구를 위한 기능성 항체 [Bio X Cell] In vivo 연구를 위한 고품질 기능성 항체 솔루션
목록 글쓰기
TOP